Artal Participations S.a r.l.

Executive

Related company / holding

Cava Group, Inc.Lexicon Pharmaceuticals, Inc.

Insider activity · 24 months0 buys1 saleCumulative net flow

Nov 24 · 0 buys · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 1 saleJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (0 ops.)

—

▼ Sales (1 ops.)

€233.7M

Latest filing published 17 Jun 2026 for Cava Group, INC., €233.7M. Read the official filing

Filing timeline

BuySale

Artal Participations S.a r.l.

Insider track record

Disclosed buys

Disclosed sells

Signal history

Artal Participations S.a r.l.: trading record in brief

Artal Participations S.a r.l. has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Cava Group, Inc. and Lexicon Pharmaceuticals, Inc. In total, 2 filings cover trades dated from 17 February 2026 to 15 June 2026.

Sales make up the whole of the open-market record (1 sale, €233.7M). The rest of the record consists of 1 share grant.

The newest entry dates from 17 June 2026: an open-market sale of €233.7M, in Cava Group, Inc. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.